Riastap
Payments companies reported to CMS as associated with Riastap. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Riastap, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Riastap
These are the largest totals companies reported as associated with Riastap. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Melissa Cushing | New York, NY | Clinical Pathology/Laboratory Medicine | $19,135.03 |
| David Faraoni | Boston, MA | Pediatric Anesthesiology | $15,983.88 |
| Daniel Katz | New York, NY | Anesthesiology | $10,218.66 |
| John Kowalczyk | Boston, MA | Anesthesiology | $8,445.68 |
| Jonathan Waters | Pittsburgh, PA | $8,115.81 | |
| Antonio Di Carlo | Philadelphia, PA | Surgery | $7,656.72 |
| Robert Desimone | Florham Park, NJ | Anesthesiology | $7,207.12 |
| Laura Downey | Atlanta, GA | Anesthesiology | $7,002.04 |
| Courtney Maxey Jones | Johnson City, NY | Anesthesiology | $6,201.03 |
| Thorsten Haas | Gainesville, FL | Anesthesiology | $5,400.00 |
Prescribed Riastap?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.